SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-068000
Filing Date
2024-03-14
Accepted
2024-03-14 16:57:01
Documents
21
Period of Report
2024-03-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d767023d8k.htm   iXBRL 8-K 38497
2 EX-3.1 d767023dex31.htm EX-3.1 86578
3 EX-10.1 d767023dex101.htm EX-10.1 173453
4 EX-99.1 d767023dex991.htm EX-99.1 8451
5 EX-99.2 d767023dex992.htm EX-99.2 19673
9 GRAPHIC g767023g0314053935945.jpg GRAPHIC 3420
10 GRAPHIC g767023g0314053936062.jpg GRAPHIC 3436
11 GRAPHIC g767023g0314054114109.jpg GRAPHIC 3234
  Complete submission text file 0001193125-24-068000.txt   553848

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA rgls-20240311.xsd EX-101.SCH 2857
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgls-20240311_lab.xml EX-101.LAB 18740
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgls-20240311_pre.xml EX-101.PRE 11712
22 EXTRACTED XBRL INSTANCE DOCUMENT d767023d8k_htm.xml XML 3852
Mailing Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121
Business Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35670 | Film No.: 24751061
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)